Clinical Trial Update: A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results on the safety and effectiveness of JNJ-39758979 in adults with persistent asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• JNJ-39758979

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Asthma | Phase 2 | Status: COMPLETED